PDL BioPharma (PDLI)
PDL BioPharma Cash Financing TTM: -193.13M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PDLI Cash Financing TTM Rankings
| Overall | 15th percentile | 3466 of 4085 |
| Sector | 9th percentile | 423 of 469 in Healthcare |
| Industry | 2nd percentile | 141 of 144 in Biotechnology |
PDLI Cash Financing TTM Range, Past 5 Years
| Minimum | -886.95M | Mar 2009 |
| Maximum | 45.58M | Mar 2008 |
| Average | -257.78M |
About Cash From Financing (TTM)
The sum of the last four quarters of a company's cash flows from financing activities.
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activites. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing debt.
Learn More
You may also be interested in these PDLI related companies
PDLI News
Stocks trading ex-dividend one week from today: http://stks.co/40f2 $BLK $BEBE $BOX $CEC $LEA $LPS $PDLI $PX ...
about 3 days ago by DynamicDividend
about 3 days ago by DynamicDividend
$PDLI http://stks.co/408f top of expanding wedge, over 6.60 BO w/ 7.10 target initally
about 4 days ago by harmongreg
about 4 days ago by harmongreg
$PDLI http://stks.co/3wcN approaching breakout point on a volume spike... http://stks.co/3wcO
about 9 days ago by TraderHR
about 9 days ago by TraderHR
@Fibline Nice list yessir, liking $SLXP from last week, bought $ARIA today, like the divy on $PDLI, hope it breaks up
about 17 days ago by harmongreg
about 17 days ago by harmongreg
@Legacy_Trades you still like $PDLI here? TA looking up, but would appreciate your FA view.
about 21 days ago by gtlackey
about 21 days ago by gtlackey
Watchlist 5/7.Careful tday but following charts look ready for a small run.$KGJI,$AFFX,$GEOY,$NAVG,$PDLI,$VNET.Look for intraday weakness.
about 25 days ago by traderNC
about 25 days ago by traderNC
PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 03, 6:52PM Seeking Alpha
May 03, 6:52PM Seeking Alpha
Listen to $PDLI Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3eza
about 28 days ago by earningscast
about 28 days ago by earningscast
PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012
Apr 27, 5:56PM PR Newswire
Apr 27, 5:56PM PR Newswire
PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
Mar 08, 4:02PM PR Newswire
Mar 08, 4:02PM PR Newswire
$PDLI forms bearish "Double Top" chart pattern. http://stks.co/2haG
about 86 days ago by RecogniaEvents
about 86 days ago by RecogniaEvents
PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
Mar 05, 4:02PM PR Newswire
Mar 05, 4:02PM PR Newswire
7 High Profitable Healthcare Dividend Stocks With Fantastic Yields + http://stks.co/2dw4 + $PDLI $AZN $PMD $GSK $BMY $NVO $SHPGY
about 91 days ago by DividendYield
about 91 days ago by DividendYield
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 23, 10:46PM Seeking Alpha
Feb 23, 10:46PM Seeking Alpha
Listen to $PDLI Q4 2011 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2XOK
about 98 days ago by earningscast
about 98 days ago by earningscast
$PDLI Reports Q4 EPS $0.24 vs $0.24 Est; Revenues $72.8M vs $72.85M Est
about 98 days ago by Benzinga
about 98 days ago by Benzinga
PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Feb 23, 4:00PM PR Newswire
Feb 23, 4:00PM PR Newswire
PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
Feb 16, 7:00AM PR Newswire
Feb 16, 7:00AM PR Newswire
Seth Klarman's Baupost Group drastically reduces PDL BioPharma $PDLI position http://stks.co/2LmR
about 111 days ago by marketfolly
about 111 days ago by marketfolly
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PDLI | 6.47 | -0.01 | -0.15% | 906.42M |
| PDII | 7.41 | -0.05 | -0.67% | 111.08M |
| PDFS | 8.84 | +0.10 | +1.14% | 248.74M |
| PDEX | 2.00 | +0.15 | +8.11% | 6.54M |
| ROG | 40.26 | +0.26 | +0.65% | 650.80M |
| RODM | 0.50 | -0.08 | -13.79% | 19.95M |
| ROCM | 9.95 | +0.00 | +0.00% | 120.40M |
| ROCK | 10.24 | +0.00 | +0.00% | 312.73M |
| ROC | 48.40 | -0.43 | -0.88% | 3.778B |
| RNWKD | 8.72 | -0.09 | -1.02% |